Lantern Pharma Inc.

NASDAQ: LTRN · Healthcare · Biotechnology

PublicHQ Dallas, TX · DallasCIK 0001763950Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 26DQ —GM —SS 43

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, market scale · ↓ Piotroski F, return on equity

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$17.1M

Employees

Market cap

$50.7M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$17.1M-$17.1M2025

Operating income-$18.0M-$18.0M2025

Total assets$11.0M$11.0M2025

Liabilities$4.5M$4.5M2025

Equity$6.5M$6.5M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Lantern Pharma Inc. earned -$17.1M in FY2025 net income.

Peers · Healthcare

Sensus Healthcare, Inc.52D Rani Therapeutics Holdings, Inc.38D Sharps Technology, Inc.30D Goldenwell Biotech, Inc.15D

Neighbors

Dallas →

Caterpillar Inc.$67.6B80B+Texas Instruments Incorporated$17.7B86A AT&T Inc.$125.6B82B+McKesson Corporation$403.4B85A Strive, Inc. Variable Rate Series A Perpetual Preferred Stock$1.5M28D Energy Transfer LP$85.5B70B

Key facts

CEOPanna Sharma

SectorHealthcare

IndustryBiotechnology

HeadquartersDallas, TX

ExchangeNASDAQ: LTRN

Employees24

IPO date2020-06-11

Latest filings

8-K2026-06-02 10-Q2026-05-15 8-K2026-05-15 8-K2026-05-14 8-K2026-04-10 8-K2026-03-30 10-K2026-03-30 8-K2026-01-23

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.